SCHEMBL6180620

SCHEMBL6180620

COc1ccc(C2CCCN2S(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.62
MAPT P10636 1/20 0.62
TRPA1 O75762 2/20 0.61
KMT2A Q03164 1/20 0.58
HCRTR1 O43613 4/20 0.55
HCRTR2 O43614 4/20 0.55
ALDH1A1 P00352 2/20 0.55
CYP3A4 P08684 1/20 0.55
USP2 O75604 1/20 0.55
GAA P10253 1/20 0.55
TSHR P16473 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
RAB9A P51151 1/20 0.54
PAX8 Q06710 1/20 0.54
CA1 P00915 1/20 0.52
FKBP1A P62942 1/20 0.52
MMP1 P03956 3/20 0.51
MMP3 P08254 3/20 0.51
MMP7 P09237 2/20 0.51
MMP9 P14780 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6180624 1.00 LMNA (0.62) LMNAMAPTTRPA1KMT2AHCRTR1
SCHEMBL6178584 0.91 TRPA1 (0.73) LMNATRPA1ALDH1A1USP2GAA
SCHEMBL6178577 0.91 TRPA1 (0.73) LMNATRPA1ALDH1A1USP2GAA
SCHEMBL6177934 0.89 TRPA1 (0.80) LMNATRPA1HCRTR1HCRTR2ALDH1A1
SCHEMBL6177932 0.89 TRPA1 (0.80) LMNATRPA1HCRTR1HCRTR2ALDH1A1
SCHEMBL6178753 0.89 PSEN1 (0.65) LMNATRPA1HCRTR1HCRTR2ALDH1A1
SCHEMBL6178750 0.89 PSEN1 (0.65) LMNATRPA1HCRTR1HCRTR2ALDH1A1
SCHEMBL6181813 0.84 TRPA1 (0.60) LMNATRPA1ALDH1A1CYP3A4USP2
SCHEMBL6177808 0.84 TRPA1 (0.86) LMNAMAPTTRPA1GAANPSR1
SCHEMBL3731913 0.84 TRPA1 (0.86) LMNAMAPTTRPA1GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO disclosed